Status:
COMPLETED
Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia
Lead Sponsor:
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Conditions:
COVID-19 Pneumonia
Brief Summary
The objective is to determine whether the use of ozone autohemotherapy is associated with a decrease in time to clinical improvement
Eligibility Criteria
Inclusion
- confirmed COVID-19 infection (diagnosed by nasopharyngeal swab performed on admission)
- severe pneumonia with baseline chest X-ray abnormalities;
- Oxygen saturation \<94% on room air, and tachypnea with respiratory rate exceeding 30 per minute.
- Informed consent signed.
Exclusion
- Not willing to participate in the study.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2020
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04444531
Start Date
March 20 2020
End Date
May 26 2020
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinic Ibiza Hospital
Ibiza Town, Spain